#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18198	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2193	825.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1704	1704	T	942	T,C	879,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18198	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2193	825.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1438	1438	C	1110	C,T	1039,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32078	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3466	921.8	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	976	C	911	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32078	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3466	921.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1650	1650	A	1130	A	1056	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32078	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3466	921.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	1019	C	934	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32078	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3466	921.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	1028	A	979	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32078	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3466	921.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	999	C,A	940,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2330	folP	855	855	100.0	folP.l15.c4.ctg.1	1508	153.5	1	SNP	p	R229S	1	.	.	685	687	AGC	973	975	AGC	253;250;251	A;G;C	237;233;229	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6048	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3388	178.1	1	SNP	p	S91F	1	.	.	271	273	TTC	514	516	TTC	209;209;210	T;T,C;C	193;192,1;196	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6048	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3388	178.1	1	SNP	p	D95G	1	.	.	283	285	GGC	526	528	GGC	210;211;210	G;G,A;C	193;192,1;188	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6048	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3388	178.1	1	SNP	p	G95N	0	.	.	283	285	GGC	526	528	GGC	210;211;210	G;G,A;C	193;192,1;188	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1894	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1439	131.4	1	SNP	p	G45D	0	.	.	133	135	GGC	561	563	GGC	239;238;240	G;G;C	224;220;224	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	992	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1039	95.0	0	.	n	.	0	A197.	DEL	197	197	A	592	592	A	214	A	205	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	209.3	1	SNP	p	D86N	0	.	.	256	258	GAC	546	548	GAC	241;243;246	G;A;C	227;220;229	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	209.3	1	SNP	p	S87R	1	.	.	259	261	CGT	549	551	CGT	244;242;244	C,A;G;T	230,1;226;226	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	209.3	1	SNP	p	R87W	0	.	.	259	261	CGT	549	551	CGT	244;242;244	C,A;G;T	230,1;226;226	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	209.3	1	SNP	p	R87I	0	.	.	259	261	CGT	549	551	CGT	244;242;244	C,A;G;T	230,1;226;226	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6114	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2913	209.3	1	SNP	p	S88P	0	.	.	262	264	TCC	552	554	TCC	243;241;243	T;C;C	225;230;229	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4796	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2712	176.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1597	1599	GGC	237;235;231	G,A;G;C	219,1;215;206	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1236	1238	GCA	234;233;238	G,A;C;A	217,1;216;224	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1239	1241	ATC	235;233;237	A;T;C	220;218;220	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1251	1253	GTG	248;249;250	G;T,G;G	231;229,1;233	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1251	1253	GTG	248;249;250	G;T,G;G	231;229,1;233	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1755	1757	ACC	208;210;210	A;C;C	184;191;192	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1809	1811	GCG	194;191;192	G;C;G	169;149;158	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1809	1811	GCG	194;191;192	G;C;G	169;149;158	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1932	1934	AGC	194;194;194	A,G;G;C,T	174,1;176;175,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1941	1943	GGC	187;184;185	G,A;G;C	167,1;167;167	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4290	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2344	181.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1959	1961	CCG	153;156;160	C,G;C,G;G	118,5;120,1;123	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6458	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3124	206.0	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1577	1579	ACG	252;251;252	A;C;G	235;234;238	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6458	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3124	206.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1715	1717	CCG	264;264;267	C;C;G	228;241;234	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2546	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1769	143.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	540	540	C	180	C	162	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	529	531	GAA	297;300;297	G;A;A	277;279;278	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	817	819	GAT	290;292;292	G;A;T,C	277;277;277,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	940	942	TCA	289;291;291	T;C;A	272;275;275	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1069	1071	GTC	284;281;281	G;T;C	265;261;263	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1081	1083	TCT	289;286;284	T;C;T	272;269;266	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1399	1401	GCA	261;265;268	G;C;A	251;254;256	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	1	SNP	p	G120K	1	.	.	358	360	AAG	775	777	AAG	249;249;246	A;A;G	242;239;236	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	1	SNP	p	A121D	1	.	.	361	363	GAC	778	780	GAC	245;244;244	G;A;C	235;235;234	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3402	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1837	184.8	1	SNP	p	D121N	0	.	.	361	363	GAC	778	780	GAC	245;244;244	G;A;C	235;235;234	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12666	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4815	262.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1448	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	994	144.1	1	SNP	p	V57M	1	.	.	169	171	ATG	486	488	ATG	309;308;306	A;T;G	291;287;286	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
